Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications

Abstract Poly(lactic acid) (PLA)/chitosan (CS) nanoparticles were prepared by emulsion method for anti-HIV drug delivery applications. The prepared PLA/CS nanoparticles were characterized using DLS, SEM, and FTIR. The hydrophilic antiretroviral drug Lamivudine was loaded into PLA/CS nanoparticles. The encapsulation efficiency and in-vitro drug release behaviour of drug loaded PLA/CS nanoparticles were studied using UV spectrophotometer. In addition, the cytotoxicity of the PLA/CS nanoparticles using MTT assay was also studied. The in-vitro drug release studies showed that drug release rate was lower in the acidic pH when compared to alkaline pH. This may due to repulsion between H + ions and cationic groups present in the polymeric nanoparticles. Drug release rate was found to be higher in the 6% drug loaded formulation when compared to 3% drug loaded formulation. These results indicated that the PLA/CS nanoparticles are a promising carrier system for controlled delivery of anti-HIV drugs.

[1]  H. Junginger,et al.  Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. , 2003, Vaccine.

[2]  Jong-Chul Park,et al.  Behavior of osteoblasts on a type I atelocollagen grafted ozone oxidized poly L-lactic acid membrane. , 2001, Biomaterials.

[3]  Soojin Park,et al.  Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique. , 2004, Journal of colloid and interface science.

[4]  Ding‐Shinn Chen,et al.  Hepatitis B genotypes and the response to interferon therapy. , 2000, Journal of hepatology.

[5]  Kwangsok Kim,et al.  Control of degradation rate and hydrophilicity in electrospun non-woven poly(D,L-lactide) nanofiber scaffolds for biomedical applications. , 2003, Biomaterials.

[6]  M. Yazdanian.  Blood-brain barrier properties of human immunodeficiency virus antiretrovirals. , 1999, Journal of pharmaceutical sciences.

[7]  E. Khor.  Chitin: Fulfilling a Biomaterials Promise , 2001 .

[8]  S. Nair,et al.  Novel chitin and chitosan nanofibers in biomedical applications. , 2010, Biotechnology advances.

[9]  R. Reis,et al.  Synthesis and Characterization of pH-Sensitive Thiol-Containing Chitosan Beads for Controlled Drug Delivery Applications , 2007, Drug delivery.

[10]  T. Aminabhavi,et al.  Controlled release of clozapine through chitosan microparticles prepared by a novel method. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[11]  N. Nguyen,et al.  Solubility behavior of lamivudine crystal forms in recrystallization solvents. , 1996, Journal of pharmaceutical sciences.

[12]  M. Wheatley,et al.  Polymeric contrast agent with targeting potential. , 2004, Ultrasonics.

[13]  K. Chennazhi,et al.  Chitosan conjugated DNA nanoparticles in gene therapy , 2010 .

[14]  Y. M. Lee,et al.  Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[15]  E. Clercq.  New developments in anti-HIV chemotherapy , 2001 .

[16]  C. Fernandes,et al.  Dissolution test for lamivudine tablets: optimization and statistical analysis. , 2006, Journal of pharmaceutical and biomedical analysis.

[17]  C. Perry,et al.  Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection. , 1997, Drugs.

[18]  P. Tarantili,et al.  The role of polymer/drug interactions on the sustained release from poly(dl-lactic acid) tablets , 2006 .

[19]  K. Anderson.  Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase. , 2002, Biochimica et biophysica acta.

[20]  R. Jayakumar,et al.  Sulfated chitin and chitosan as novel biomaterials. , 2007, International journal of biological macromolecules.

[21]  O'donnell,et al.  Preparation of microspheres by the solvent evaporation technique. , 1997, Advanced drug delivery reviews.

[22]  J. Mano,et al.  Chitosan-Based Particles as Controlled Drug Delivery Systems , 2004, Drug delivery.

[23]  Changyou Gao,et al.  Paraffin spheres as porogen to fabricate poly(L-lactic acid) scaffolds with improved cytocompatibility for cartilage tissue engineering. , 2003, Journal of biomedical materials research. Part B, Applied biomaterials.

[24]  M. Prabaharan,et al.  Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery. , 2009, Biomaterials.

[25]  W C de Bruijn,et al.  Late degradation tissue response to poly(L-lactide) bone plates and screws. , 1995, Biomaterials.

[26]  R. Ruseckaite,et al.  Structural changes of polylactic‐acid (PLA) microspheres under hydrolytic degradation , 1999 .

[27]  R. Reis,et al.  GRAFT COPOLYMERIZED CHITOSAN-PRESENT STATUS AND APPLICATIONS , 2005 .